Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bath & Body Works, Inc.BBWI · Entity 4091 | Director | June 11, 2026 | June 15, 2026 |
| EXELON CORPEXC · Entity 3050 | Director | March 31, 2020 | April 01, 2020 |
| HUNTINGTON BANCSHARES INC /MD/HBAN · Entity 3125 | Director · Chairman & CEO | October 01, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bath & Body Works, Inc.
Report date June 11, 2026 · Filed June 15, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.50 par valueSEC Table I · non-derivative | Direct | 56,145 |
Reported balance
After 2026-06-11 transaction · row 1
1 source rowRow 1 · 2026-06-11 · Grant · Acquired 7,970 · Balance 56,145 F1: Annual award of restricted stock units to independent non-employee directors. |
| Common Stock, $0.50 par valueSEC Table I · non-derivative | IndirectBy Spouse | 12,925 |
Reported balance
Holding disclosure · report date 2026-06-11 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 12,925 |
| Common Stock, $0.50 par valueSEC Table I · non-derivative | IndirectPatricia M. Steinour Legacy Trust dated 10/14/2016 | 9,900 |
Reported balance
Holding disclosure · report date 2026-06-11 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 9,900 |
| Common Stock, $0.50 par valueSEC Table I · non-derivative | IndirectStephen D. Steinour Dynasty Trust dated 6/1/2016 | 9,900 |
Reported balance
Holding disclosure · report date 2026-06-11 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 9,900 |
Filing footnotes · ownership attribution and instrument terms
F1: Annual award of restricted stock units to independent non-employee directors.
EXELON CORP
Report date March 31, 2020 · Filed April 01, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock (Deferred Stock Units)SEC Table I · non-derivative | IndirectBy Exelon Directors' Deferred Stock Unit Plan | 44,773 |
Reported balance
After 2020-03-31 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2020-03-31 · Grant · Acquired 899 · Balance 44,773 F1: Balance includes 386 shares acquired on March 10, 2020 through automatic dividend reinvestment. |
| Deferred Comp. Phantom Share EquivalentsSEC Table II · derivative / convertible security | Direct | 50,357 |
Reported balance
After 2020-03-31 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2020-03-31 · Grant · Acquired 848 · Balance 50,357 F2: Phantom share equivalents acquired in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service on the Exelon board of directors. Balance also reflects 372 share equivalents accrued on February 19, 2020 through automatic dividend reinvestment. |
| Common StockSEC Table I · non-derivative | Direct | 3,189 |
Reported balance
Holding disclosure · report date 2020-03-31 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 3,189 |
| Common StockSEC Table I · non-derivative | IndirectHeld by trust for benefit of son | 1,063 |
Reported balance
Holding disclosure · report date 2020-03-31 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,063 |
Filing footnotes · ownership attribution and instrument terms
F1: Balance includes 386 shares acquired on March 10, 2020 through automatic dividend reinvestment.
F2: Phantom share equivalents acquired in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan and that will be settled in cash on a 1 for 1 basis upon the termination of the reporting person's service on the Exelon board of directors. Balance also reflects 372 share equivalents accrued on February 19, 2020 through automatic dividend reinvestment.
HUNTINGTON BANCSHARES INC /MD/
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,497,812.989 |
Reported balance
After 2026-10-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 7,250.127 · Balance 1,497,812.989 F1: Total includes the transfer of shares from grantor retained annuity trust. |
| Common StockSEC Table I · non-derivative | IndirectBy Issuer's Investment and Tax Savings Plan (401(k) Plan) | 57,579.744 |
Reported balance
After 2026-10-01 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-10-01 · Grant · Acquired 591.473 · Balance 57,579.744 F2: The filing of this statement shall not be construed as an admission that the undersigned is, for the purpose of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of the securities. |
| Common StockSEC Table I · non-derivative | IndirectBy Executive Deferred Compensation Plan | 3,502,975.527 |
Reported balance
Holding disclosure · report date 2026-10-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 3,502,975.527 F2: The filing of this statement shall not be construed as an admission that the undersigned is, for the purpose of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of the securities. |
| Common StockSEC Table I · non-derivative | IndirectBy Family Trusts | 3,077,505 |
Reported balance
Holding disclosure · report date 2026-10-01 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 3,077,505 F2: The filing of this statement shall not be construed as an admission that the undersigned is, for the purpose of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of the securities. |
| Common StockSEC Table I · non-derivative | Indirectby GRATS | 840,000 |
Reported balance
Holding disclosure · report date 2026-10-01 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 840,000 F3: Reflects the transfer of shares from grantor retained annuity trust to directly-held shares. F2: The filing of this statement shall not be construed as an admission that the undersigned is, for the purpose of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of the securities. |
| Common StockSEC Table I · non-derivative | IndirectBy Issuer's Supplemental Stock Purchase and Tax Savings Plan | 90,363.268 |
Reported balance
Holding disclosure · report date 2026-10-01 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 90,363.268 F2: The filing of this statement shall not be construed as an admission that the undersigned is, for the purpose of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of the securities. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 1,924.43 |
Reported balance
Holding disclosure · report date 2026-10-01 · row 7
Holding and transaction disclosures are not merged.
1 source rowRow 7 · Balance 1,924.43 F2: The filing of this statement shall not be construed as an admission that the undersigned is, for the purpose of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of the securities. |
Filing footnotes · ownership attribution and instrument terms
F1: Total includes the transfer of shares from grantor retained annuity trust.
F2: The filing of this statement shall not be construed as an admission that the undersigned is, for the purpose of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of the securities.
F3: Reflects the transfer of shares from grantor retained annuity trust to directly-held shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 06, 2018 Filed Feb 14, 2022 13:04 UTC | Bath & Body Works, Inc. BBWI · Entity 4091 | GiftCommon Stock, $0.50 par value | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-001974 · doc5.xml · nonDerivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 13:58 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | Tax withholdingCommon Stock | 11,779 | $15.70 | $184,930.30 |
DisclosureSEC source: 0001225208-18-005047 · doc4.xml · nonDerivative · entry 2 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,013,035 F2 · shares: Shares were withheld to cover the associated tax liability upon the vesting of a previously granted award of RSUs. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 13:58 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | GrantCommon Stock | 22,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-005047 · doc4.xml · nonDerivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,024,814 F1 · shares: An award of restricted stock units that vests in shares of common stock in three equal annual increments beginning on the first anniversary of the date of grant. Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 22:47 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | Exercise / conversionEmployee/Director Stock Option (Right to Buy) · Derivative | 230,035 | $6.02 Strike: $6.02 | $1,384,810.70 |
DisclosureSEC source: 0001225208-18-003856 · doc4.xml · derivative · entry 8 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,610,250 Underlying: Common Stock · 230,035 shares Expires 2018-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 22:47 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | Tax withholdingCommon Stock | 151,167 | $16.16 | $2,442,102.89 |
DisclosureSEC source: 0001225208-18-003856 · doc4.xml · nonDerivative · entry 2 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,002,522 Read SEC document |
| February 21, 2018 Filed Feb 22, 2018 22:47 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | Exercise / conversionCommon Stock | 230,035 | $6.02 | $1,384,810.70 |
DisclosureSEC source: 0001225208-18-003856 · doc4.xml · nonDerivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,153,689 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2018 Filed Feb 20, 2018 21:57 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | Tax withholdingCommon Stock | 12,162 | $15.83 | $192,524.46 |
DisclosureSEC source: 0001225208-18-003396 · doc4.xml · nonDerivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,923,654 F1 · shares: Shares were withheld to cover the associated tax liability upon the vesting of a previously granted award of RSUs. Read SEC document |
| February 09, 2018 Filed Feb 12, 2018 21:44 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | OtherCommon Stock | 24,776 | $15.22 | $377,122.93 |
DisclosureSEC source: 0001225208-18-002506 · doc4.xml · nonDerivative · entry 2 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · By Executive Deferred Compensation Plan Disclosed balance after: 41,557 Read SEC document |
| February 05, 2018 Filed Feb 7, 2018 17:31 UTC | Bath & Body Works, Inc. LB · Entity 4091 | GrantPhantom Stock · Derivative | 595 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002198 · doc4.xml · derivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,158 Underlying: Common Stock, $0.50 par value · 595 shares Expires not disclosed F1 · derivative.exercise_price: This award converts to common stock on a 1-for-1 basis. F2 · derivative.exercise_date: The shares of phantom stock become payable upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: The shares of phantom stock become payable upon the reporting person's termination of service as a director. F3 · balance_after: Total holdings include shares acquired in exempt dividend reinvestment transactions. Read SEC document |
| January 26, 2018 Filed Jan 29, 2018 17:36 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | Exercise / conversionEmployee/Director Stock Option (Right to Buy) · Derivative | 230,035 | $0.00 Strike: $6.02 | $0.00 |
DisclosureSEC source: 0001225208-18-001712 · doc4.xml · derivative · entry 8 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,840,285 Underlying: Common Stock · 230,035 shares Expires 2018-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2018 Filed Jan 29, 2018 17:36 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | Tax withholdingCommon Stock | 142,048 | $16.13 | $2,291,234.24 |
DisclosureSEC source: 0001225208-18-001712 · doc4.xml · nonDerivative · entry 2 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,030,816 Read SEC document |
| January 26, 2018 Filed Jan 29, 2018 17:36 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | Exercise / conversionCommon Stock | 230,035 | $6.02 | $1,384,810.70 |
DisclosureSEC source: 0001225208-18-001712 · doc4.xml · nonDerivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,172,864 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 31, 2017 Filed Jan 2, 2018 22:34 UTC | EXELON CORP EXC · Entity 3050 | GrantDeferred Comp. Phantom Share Equivalents · Derivative | 920 | $39.41 | $36,257.20 |
DisclosureSEC source: 0001109357-18-000012 · edgar.xml · derivative · entry 4 STEINOUR STEPHEN D · CIK 0001213991 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,749 Underlying: Common Stock · 920 shares Expires not disclosed F3 · derivative.exercise_price: Phantom share equivalents acquired through regular periodic contributions of deferred board compensation and the reinvestment of dividend equivalents in reporting person's Exelon stock fund account under multi-fund, non-qualified deferred compensation plan. The unitized fund consists of Exelon common stock and short term investments and will be settled in cash upon the reporting person's separation from the board for any reason. The balance of such phantom share equivalents may fluctuate from time to time due to fluctuations in the fund composition. F3 · derivative.exercise_date: Phantom share equivalents acquired through regular periodic contributions of deferred board compensation and the reinvestment of dividend equivalents in reporting person's Exelon stock fund account under multi-fund, non-qualified deferred compensation plan. The unitized fund consists of Exelon common stock and short term investments and will be settled in cash upon the reporting person's separation from the board for any reason. The balance of such phantom share equivalents may fluctuate from time to time due to fluctuations in the fund composition. F3 · derivative.expiration_date: Phantom share equivalents acquired through regular periodic contributions of deferred board compensation and the reinvestment of dividend equivalents in reporting person's Exelon stock fund account under multi-fund, non-qualified deferred compensation plan. The unitized fund consists of Exelon common stock and short term investments and will be settled in cash upon the reporting person's separation from the board for any reason. The balance of such phantom share equivalents may fluctuate from time to time due to fluctuations in the fund composition. F4 · balance_after: Balance includes 300 share equivalents accrued on November 14, 2017 through automatic dividend reinvestment. Read SEC document |
| December 31, 2017 Filed Jan 2, 2018 22:34 UTC | EXELON CORP EXC · Entity 3050 | GrantCommon Stock (Deferred Stock Units) | 883 | $41.05 | $36,247.15 |
DisclosureSEC source: 0001109357-18-000012 · edgar.xml · nonDerivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 34,367 F1 · balance_after: Balance includes 265 shares acquired on December 8, 2017 through automatic dividend reinvestment. Read SEC document |
| December 22, 2017 Filed Feb 12, 2018 21:44 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | GiftCommon Stock | 95,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002506 · doc4.xml · nonDerivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,847,829 Read SEC document |
| October 30, 2017 Filed Nov 1, 2017 18:28 UTC | Bath & Body Works, Inc. LB · Entity 4091 | GrantPhantom Stock · Derivative | 653 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-016720 · doc4.xml · derivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,422 Underlying: Common Stock, $0.50 par value · 653 shares Expires not disclosed F1 · derivative.exercise_price: This award converts to common stock on a 1-for-1 basis. F2 · derivative.exercise_date: The shares of phantom stock become payable upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: The shares of phantom stock become payable upon the reporting person's termination of service as a director. F3 · balance_after: Total holdings include shares acquired in exempt dividend reinvestment transactions. Read SEC document |
| September 30, 2017 Filed Oct 2, 2017 21:49 UTC | EXELON CORP EXC · Entity 3050 | GrantCommon Stock (Deferred Stock Units) | 950 | $38.17 | $36,261.50 |
DisclosureSEC source: 0001109357-17-000082 · edgar.xml · nonDerivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 33,218 F1 · balance_after: Balance includes 275 shares acquired on September 8, 2017 through automatic dividend reinvestment. Read SEC document |
| September 29, 2017 Filed Oct 2, 2017 21:49 UTC | EXELON CORP EXC · Entity 3050 | GrantDeferred Comp. Phantom Share Equivalents · Derivative | 961 | $37.67 | $36,200.87 |
DisclosureSEC source: 0001109357-17-000082 · edgar.xml · derivative · entry 4 STEINOUR STEPHEN D · CIK 0001213991 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,558 Underlying: Common Stock · 961 shares Expires not disclosed F3 · derivative.exercise_price: Phantom share equivalents acquired through regular periodic contributions of deferred board compensation and the reinvestment of dividend equivalents in reporting person's Exelon stock fund account under multi-fund, non-qualified deferred compensation plan. The unitized fund consists of Exelon common stock and short term investments and will be settled in cash upon the reporting person's separation from the board for any reason. The balance of such phantom share equivalents may fluctuate from time to time due to fluctuations in the fund composition. F3 · derivative.exercise_date: Phantom share equivalents acquired through regular periodic contributions of deferred board compensation and the reinvestment of dividend equivalents in reporting person's Exelon stock fund account under multi-fund, non-qualified deferred compensation plan. The unitized fund consists of Exelon common stock and short term investments and will be settled in cash upon the reporting person's separation from the board for any reason. The balance of such phantom share equivalents may fluctuate from time to time due to fluctuations in the fund composition. F3 · derivative.expiration_date: Phantom share equivalents acquired through regular periodic contributions of deferred board compensation and the reinvestment of dividend equivalents in reporting person's Exelon stock fund account under multi-fund, non-qualified deferred compensation plan. The unitized fund consists of Exelon common stock and short term investments and will be settled in cash upon the reporting person's separation from the board for any reason. The balance of such phantom share equivalents may fluctuate from time to time due to fluctuations in the fund composition. F4 · balance_after: Balance includes 327 share equivalents accrued on August 11, 2017 through automatic dividend reinvestment. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 14:00 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | Exercise / conversionEmployee/Director Stock Option (Right to Buy) · Derivative | 29,833 | $0.00 Strike: $6.02 | $0.00 |
DisclosureSEC source: 0001225208-17-013352 · doc4.xml · derivative · entry 7 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,070,320 Underlying: Common Stock · 29,833 shares Expires 2018-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 14:00 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | Exercise / conversionCommon Stock | 29,833 | $6.02 | $179,594.66 |
DisclosureSEC source: 0001225208-17-013352 · doc4.xml · nonDerivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,942,829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 31, 2017 Filed Aug 2, 2017 19:56 UTC | Bath & Body Works, Inc. LB · Entity 4091 | GrantPhantom Stock · Derivative | 603 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-013150 · doc4.xml · derivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,567 Underlying: Common Stock, $0.50 par value · 603 shares Expires not disclosed F1 · derivative.exercise_price: This award converts to common stock on a 1-for-1 basis. F2 · derivative.exercise_date: The shares of phantom stock become payable upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: The shares of phantom stock become payable upon the reporting person's termination of service as a director. F3 · balance_after: Total holdings include shares acquired in exempt dividend reinvestment transactions. Read SEC document |
| June 30, 2017 Filed Jul 3, 2017 17:19 UTC | EXELON CORP EXC · Entity 3050 | GrantDeferred Comp. Phantom Share Equivalents · Derivative | 1,005 | $36.07 | $36,250.35 |
DisclosureSEC source: 0001109357-17-000067 · edgar.xml · derivative · entry 4 STEINOUR STEPHEN D · CIK 0001213991 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,294 Underlying: Common Stock · 1,005 shares Expires not disclosed F3 · derivative.exercise_price: Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's separation from the board for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions of deferred board compensation and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate from time to time due to fluctuations in the fund composition. F3 · derivative.exercise_date: Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's separation from the board for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions of deferred board compensation and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate from time to time due to fluctuations in the fund composition. F3 · derivative.expiration_date: Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's separation from the board for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions of deferred board compensation and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate from time to time due to fluctuations in the fund composition. F4 · balance_after: Balance includes 358 share equivalents accrued on May 11, 2017 through automatic dividend reinvestment. Read SEC document |
| June 30, 2017 Filed Jul 3, 2017 17:19 UTC | EXELON CORP EXC · Entity 3050 | GrantCommon Stock (Deferred Stock Units) | 990 | $36.62 | $36,253.80 |
DisclosureSEC source: 0001109357-17-000067 · edgar.xml · nonDerivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 31,994 F1 · balance_after: Balance includes 275 shares acquired on June 9, 2017 through automatic dividend reinvestment. Read SEC document |
| May 18, 2017 Filed May 18, 2017 17:35 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | PurchaseCommon Stock | 1,400 | $12.40 | $17,354.40 |
DisclosureSEC source: 0001225208-17-010022 · doc4.xml · nonDerivative · entry 4 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,912,996 Read SEC document |
| May 18, 2017 Filed May 18, 2017 17:35 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | PurchaseCommon Stock | 2,200 | $12.40 | $27,269.00 |
DisclosureSEC source: 0001225208-17-010022 · doc4.xml · nonDerivative · entry 3 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,911,596 Read SEC document |
| May 18, 2017 Filed May 18, 2017 17:35 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | PurchaseCommon Stock | 17,565 | $12.39 | $217,630.35 |
DisclosureSEC source: 0001225208-17-010022 · doc4.xml · nonDerivative · entry 2 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,909,396 Read SEC document |
| May 18, 2017 Filed May 18, 2017 17:35 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | PurchaseCommon Stock | 28,835 | $12.40 | $357,554.00 |
DisclosureSEC source: 0001225208-17-010022 · doc4.xml · nonDerivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,891,831 Read SEC document |
| May 01, 2017 Filed May 3, 2017 20:06 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | GrantEmployee/Director Stock Option (Right to Buy) · Derivative | 266,903 | $0.00 Strike: $13.09 | $0.00 |
DisclosureSEC source: 0001225208-17-009014 · doc4.xml · derivative · entry 9 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,903 Underlying: Common Stock · 266,903 shares Expires 2027-05-01 F3 · derivative.exercise_date: The options become exercisable in 4 equal annual increments beginning on the first anniversary of the date of grant. The date reported is the first anniversary when a portion of the options first become exercisable. Read SEC document |
| May 01, 2017 Filed May 3, 2017 20:06 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | Tax withholdingCommon Stock | 7,945 | $13.09 | $104,000.05 |
DisclosureSEC source: 0001225208-17-009014 · doc4.xml · nonDerivative · entry 3 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,862,996 F2 · shares: Shares were withheld to cover the associated tax liability upon the vesting of a previously granted award of RSUs. Read SEC document |
| May 01, 2017 Filed May 3, 2017 20:06 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | Tax withholdingCommon Stock | 6,488 | $13.09 | $84,927.92 |
DisclosureSEC source: 0001225208-17-009014 · doc4.xml · nonDerivative · entry 2 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,870,941 F2 · shares: Shares were withheld to cover the associated tax liability upon the vesting of a previously granted award of RSUs. Read SEC document |
| May 01, 2017 Filed May 3, 2017 20:06 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | GrantCommon Stock | 133,689 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-009014 · doc4.xml · nonDerivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,877,429 F1 · shares: An award of restricted stock units, to be released in shares of common stock, that vests in two equal installments: 50% on the third anniversary of the date of grant and 50% on the fourth anniversary of the date of grant. Read SEC document |
| May 01, 2017 Filed May 3, 2017 20:10 UTC | Bath & Body Works, Inc. LB · Entity 4091 | GrantPhantom Stock · Derivative | 539 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-009027 · doc4.xml · derivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,827 Underlying: Common Stock, $0.50 par value · 539 shares Expires not disclosed F1 · derivative.exercise_price: This award converts to common stock on a 1-for-1 basis. F2 · derivative.exercise_date: The shares of phantom stock become payable upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: The shares of phantom stock become payable upon the reporting person's termination of service as a director. F3 · balance_after: Total holdings include shares acquired in exempt dividend reinvestment transactions. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 20:21 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | Tax withholdingCommon Stock | 80,465 | $12.59 | $1,013,054.35 |
DisclosureSEC source: 0001225208-17-008256 · doc4.xml · nonDerivative · entry 2 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,743,740 Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 20:21 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | GrantCommon Stock | 304,789 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-008256 · doc4.xml · nonDerivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,824,205 Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 20:39 UTC | Bath & Body Works, Inc. LB · Entity 4091 | GrantPhantom Stock · Derivative | 2,376 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-007422 · doc4.xml · derivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,288 Underlying: Common Stock, $0.50 par value · 2,376 shares Expires not disclosed F1 · derivative.exercise_price: This award converts to common stock on a 1-for-1 basis. F2 · derivative.exercise_date: The shares of phantom stock become payable upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: The shares of phantom stock become payable upon the reporting person's termination of service as a director. F3 · balance_after: Total holdings include shares acquired in exempt dividend reinvestment transactions. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 14:16 UTC | EXELON CORP EXC · Entity 3050 | GrantDeferred Comp. Phantom Share Equivalents · Derivative | 1,008 | $35.98 | $36,267.84 |
DisclosureSEC source: 0001109357-17-000051 · edgar.xml · derivative · entry 4 STEINOUR STEPHEN D · CIK 0001213991 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,998 Underlying: Common Stock · 1,008 shares Expires not disclosed F3 · derivative.exercise_price: Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's separation from the board for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions of deferred board compensation and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate from time to time due to fluctuations in the fund composition. F3 · derivative.exercise_date: Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's separation from the board for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions of deferred board compensation and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate from time to time due to fluctuations in the fund composition. F3 · derivative.expiration_date: Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's separation from the board for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions of deferred board compensation and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate from time to time due to fluctuations in the fund composition. F4 · balance_after: Balance includes 329 share equivalents accrued on February 13, 2017 through automatic dividend reinvestment. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 14:16 UTC | EXELON CORP EXC · Entity 3050 | GrantCommon Stock (Deferred Stock Units) | 1,008 | $35.97 | $36,257.76 |
DisclosureSEC source: 0001109357-17-000051 · edgar.xml · nonDerivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 30,730 F1 · balance_after: Balance includes 268 shares acquired on March 10, 2017 through automatic dividend reinvestment. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 11:01 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | Tax withholdingCommon Stock | 3,578 | $14.13 | $50,557.14 |
DisclosureSEC source: 0001225208-17-003808 · doc4.xml · nonDerivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,519,416 F1 · shares: Shares were withheld to cover the associated tax liability upon the vesting of a previously granted award of RSUs. Read SEC document |
| February 16, 2017 Filed Feb 17, 2017 21:11 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | Tax withholdingCommon Stock | 5,234 | $14.17 | $74,165.78 |
DisclosureSEC source: 0001225208-17-003759 · doc4.xml · nonDerivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,522,994 F1 · shares: Shares were withheld to cover the associated tax liability upon the vesting of a previously granted award of RSUs . Read SEC document |
| February 14, 2017 Filed Feb 16, 2017 22:53 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | GrantCommon Stock | 93,974 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003610 · doc4.xml · nonDerivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,528,228 F1 · shares: This is an award of restricted stock units. The award will vest in shares of common stock over 3 years - one-third upon February 28 of each of the 3 years following the date of grant. Read SEC document |
| February 11, 2017 Filed Feb 14, 2017 20:41 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | Tax withholdingCommon Stock | 2,904 | $13.62 | $39,552.48 |
DisclosureSEC source: 0001225208-17-003197 · doc4.xml · nonDerivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,434,254 F1 · shares: Shares were withheld to cover the associated tax liability upon the vesting of a previously granted award of RSUs . Read SEC document |
| February 03, 2017 Filed Feb 6, 2017 22:10 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | Exercise / conversionEmployee/Director Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $6.02 | $0.00 |
DisclosureSEC source: 0001225208-17-002457 · doc4.xml · derivative · entry 8 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,100,153 Underlying: Common Stock · 20,000 shares Expires 2018-07-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 03, 2017 Filed Feb 6, 2017 22:10 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | Exercise / conversionCommon Stock | 20,000 | $6.02 | $120,400.00 |
DisclosureSEC source: 0001225208-17-002457 · doc4.xml · nonDerivative · entry 2 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,437,158 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 21:51 UTC | Bath & Body Works, Inc. LB · Entity 4091 | GrantPhantom Stock · Derivative | 476 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-002183 · doc4.xml · derivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,811 Underlying: Common Stock, $0.50 par value · 476 shares Expires not disclosed F1 · derivative.exercise_price: This award converts to common stock on a 1-for-1 basis. F2 · derivative.exercise_date: The shares of phantom stock become payable upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: The shares of phantom stock become payable upon the reporting person's termination of service as a director. F3 · balance_after: Total holdings include shares acquired in exempt dividend reinvestment transactions. Read SEC document |
| December 31, 2016 Filed Jan 4, 2017 15:03 UTC | EXELON CORP EXC · Entity 3050 | GrantCommon Stock (Deferred Stock Units) | 1,039 | $34.90 | $36,261.10 |
DisclosureSEC source: 0001109357-17-000012 · edgar.xml · nonDerivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 29,455 F1 · balance_after: Balance includes 257 shares acquired on December 9, 2016 through automatic dividend reinvestment. Read SEC document |
| December 30, 2016 Filed Jan 4, 2017 15:03 UTC | EXELON CORP EXC · Entity 3050 | GrantDeferred Comp. Phantom Share Equivalents · Derivative | 1,021 | $35.49 | $36,235.29 |
DisclosureSEC source: 0001109357-17-000012 · edgar.xml · derivative · entry 4 STEINOUR STEPHEN D · CIK 0001213991 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,725 Underlying: Common Stock · 1,021 shares Expires not disclosed F3 · derivative.exercise_price: Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's separation from the board for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions of deferred board compensation and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate from time to time due to fluctuations in the fund composition. F3 · derivative.exercise_date: Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's separation from the board for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions of deferred board compensation and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate from time to time due to fluctuations in the fund composition. F3 · derivative.expiration_date: Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's separation from the board for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions of deferred board compensation and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate from time to time due to fluctuations in the fund composition. F4 · balance_after: Balance includes 351 share equivalents accrued on November 10, 2016 through automatic dividend reinvestment. Read SEC document |
| November 29, 2016 Filed Feb 6, 2017 22:10 UTC | HUNTINGTON BANCSHARES INC /MD/ HBAN · Entity 3125 | GiftCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-002457 · doc4.xml · nonDerivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director · President, CEO & Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,417,158 Read SEC document |
| October 31, 2016 Filed Nov 2, 2016 18:54 UTC | Bath & Body Works, Inc. LB · Entity 4091 | GrantPhantom Stock · Derivative | 387 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-040983 · doc4.xml · derivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,265 Underlying: Common Stock, $0.50 par value · 387 shares Expires not disclosed F1 · derivative.exercise_price: This award converts to common stock on a 1-for-1 basis. F2 · derivative.exercise_date: The shares of phantom stock become payable upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: The shares of phantom stock become payable upon the reporting person's termination of service as a director. F3 · balance_after: Total holdings include shares acquired in exempt dividend reinvestment transactions. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 14:21 UTC | EXELON CORP EXC · Entity 3050 | GrantDeferred Comp. Phantom Share Equivalents · Derivative | 1,143 | $33.29 | $38,050.47 |
DisclosureSEC source: 0001109357-16-000163 · edgar.xml · derivative · entry 4 STEINOUR STEPHEN D · CIK 0001213991 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,405 Underlying: Common Stock · 1,143 shares Expires not disclosed F3 · derivative.exercise_price: Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's separation from the board for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions of deferred board compensation and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate from time to time due to fluctuations in the fund composition. F3 · derivative.exercise_date: Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's separation from the board for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions of deferred board compensation and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate from time to time due to fluctuations in the fund composition. F3 · derivative.expiration_date: Phantom share equivalents representing units held in the Exelon stock fund in a multi-fund, non-qualified deferred compensation plan. The Exelon stock fund is a unitized fund that consists of Exelon common stock and short term investments. Units of the fund will be settled upon the reporting person's separation from the board for any reason. Units will be settled in cash. Units are acquired through regular periodic contributions of deferred board compensation and the reinvestment of dividend equivalents. The balance of phantom share equivalents may fluctuate from time to time due to fluctuations in the fund composition. F4 · balance_after: Balance includes 293 share equivalents accrued on August 11, 2016 through automatic dividend reinvestment. Read SEC document |
| September 30, 2016 Filed Oct 4, 2016 14:21 UTC | EXELON CORP EXC · Entity 3050 | GrantCommon Stock (Deferred Stock Units) | 972 | $33.40 | $32,464.80 |
DisclosureSEC source: 0001109357-16-000163 · edgar.xml · nonDerivative · entry 1 STEINOUR STEPHEN D · CIK 0001213991 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Exelon Directors' Deferred Stock Unit Plan Disclosed balance after: 28,158 F1 · balance_after: Balance includes 256 shares acquired on September 9, 2016 through automatic dividend reinvestment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.